An experimental drug zaps the malaria parasite at multiple stages of infection, tests in mice show. And it may have an important upside: it doesn’t appear prone to drug resistance, the Achilles’ heel of malaria medicines.
While preliminary, the findings offer welcome news in a field beset by uneven performance as the malaria protozoa subvert drug after drug.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.